NCT05424575 is a clinical trial in Frailty Syndrome, sponsored by Ankara University.

Who is sponsoring NCT05424575?

NCT05424575 is sponsored by Ankara University.

What condition does NCT05424575 study?

NCT05424575 studies Frailty Syndrome, Postoperative Complications.

Is NCT05424575 still recruiting?

NCT05424575 is currently completed. Last updated 21 June 2022.

Last reviewed 2022-06-21 · How we verify

NCT05424575

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Modified Fraility Index in Patients Undergoing Arthroplasty

Completed Last updated 21 June 2022

What this trial tests

trial in Frailty Syndrome in 145 participants. Completed in 25 January 2021.

Timeline

20 July 2020

Primary endpoint
20 October 2020

25 January 2021

Quick facts

Lead sponsor	Ankara University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	145
Start date	20 July 2020
Primary completion	20 October 2020
Estimated completion	25 January 2021
Sites	1 location across Turkey (Türkiye)

Conditions studied

Frailty Syndrome — all drugs for Frailty Syndrome →
Postoperative Complications — all drugs for Postoperative Complications →

Sponsor

Ankara University

Who can join

Adults 45 to 85, any sex, with Frailty Syndrome or Postoperative Complications. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The authors aimed to evaluate the relation between Modified Fraility Index (MFI) and postoperative complications (myocardial infarction, cardiac arrest, pulmonary embolism, septic shock, postoperative dialysis requirement, cerebrovascular event, reintubation, prolonged mechanical ventilation, surgical wound complications), duration of hospitalization, requirement for intensive care unit (ICU) admission and rehospitalization and 30th day mortality in patients undergoing arthroplasy.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Modified frailty index (mFI): is it a predictor for early postoperative complications in arthroplasty surgery?
Alıbaylı L, Cakar Turhan KS, Baytas V, Karadag Erkoc S, et al · · 2024 · cited 4× · PMID 38375705 · DOI 10.26355/eurrev_202402_35336

Verify or expand the search:

Other recruiting trials for Frailty Syndrome

Currently open trials in the same condition.

NCT07465159 — Multimodal Prehabilitation of Frail Patients Undergoing Elective Knee or Hip Replacement · NA · recruiting
NCT07258615 — Longitudinal Ultrasound Assessment of Diaphragmatic and Respiratory Muscle Function Following Respiratory Muscle Trainin · NA · active not recruiting
NCT07348081 — Real World Evidence to Assess the Value of a Digital Care Coordination and Monitoring Program for Supporting Caregivers · NA · recruiting
NCT07338929 — Physical Performance Assessment in Kidney Transplant Evaluation · recruiting
NCT07071142 — Frailty and Outcomes in Older Heart Failure Patients With Ejection Fraction >40% · active not recruiting

Other Ankara University trials

Trials by the same sponsor.

NCT07441837 — Terbium 161 PSMA in Lutetium-177 PSMA Naive Patients · Phase 2 · not yet recruiting
NCT07536490 — Sleep Quality, Cognition, and Disease Severity in Parkinson's Disease · not yet recruiting
NCT06959433 — Lu-177 PSMA Treatment in Cell Renal Carcinoma · Phase 3 · not yet recruiting
NCT07513272 — EFFECT OF BALLS ON PAIN AND ANXIETY DURING VENIPUNCTURE IN CHILDREN · NA · not yet recruiting
NCT07536542 — Effects of Dual-Task Training on Upper Extremity Function in Parkinson's Disease · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05424575 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ankara University
Last refreshed: 21 June 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05424575.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing